Le Lézard
Classified in: Health
Subjects: EXE, FDA

FDA approves first test for screening Zika virus in blood donations



SILVER SPRING, Md., Oct. 5, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors. It is intended for use by blood collection establishments to detect Zika virus in blood donations, not for the individual diagnosis of Zika virus infection.

U.S. Food and Drug Administration (FDA) logo (PRNewsFoto/FDA)

"Today's action represents the first approval of a Zika virus detection test for use with screening the nation's blood supply," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research. "Screening blood donations for the Zika virus is critical to preventing infected donations from entering the U.S. blood supply. Today's approval is the result of a commitment by the manufacturer to work rapidly and collaboratively with the FDA and the blood collection industry to respond to a public health crisis and ensure the safety of blood in the U.S. and its territories."

In August 2016, the FDA issued a final guidance document recommending that all states and territories screen individual units of whole blood and blood components with an investigational blood screening test available under an investigational new drug (IND) application, or a licensed (approved) test when available.

Before today, several blood collection establishments used the cobas Zika test under IND in order to follow the recommendations in the FDA's 2016 guidance document. The data collected from this testing, and from additional studies performed by the manufacturer, demonstrated that the cobas Zika test is an effective test to screen blood donors for Zika virus infection. The test's clinical specificity was evaluated by testing individual samples from blood donations at five external laboratory sites, resulting in clinical specificity of more than 99 percent.

The Zika virus is transmitted primarily by mosquitos (Aedes aegypti), but it can also be spread through blood transfusion and sexual contact. Although most people infected with Zika virus do not develop symptoms, when symptoms do occur they may include fever, arthralgia (joint pain), maculopapular rash (red area with small bumps), and conjunctivitis (red, irritated eyes). In addition, Zika virus infection can cause a serious neurological disease in adults, and infection during pregnancy can cause serious birth defects.

The cobas Zika test is intended for use on the fully automated cobas 6800 and cobas 8800 systems. The cobas Zika test, cobas 6800, and cobas 8800 systems are manufactured by Roche Molecular Systems, Inc.

Related information:
FDA: Infectious Disease Tests 
FDA: Zika Virus Updates

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines, and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Tara Goodin, 240-402-3157, tara.goodin@fda.hhs.gov 
Consumer Inquiries: 888-INFO-FDA, OCOD@fda.hhs.gov

 

SOURCE U.S. Food and Drug Administration


These press releases may also interest you

at 10:05
Array BioPharma Inc. and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab,...

at 10:00
The 15th Guignolée du Dr Julien ended this week with a total of $1,744,000 raised in support of the Fondation du Dr Julien's three centres of expertise (CSPC Hochelaga-Maisonneuve, CSPC Côte-des-Neiges and Garage à musique). This amount represents...

at 08:00
Taiho Oncology, Inc. and Servier today announced clinical data for LONSURF® (trifluridine and tipiracil) for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluropyrimidine-, oxaliplatin- and...

at 03:15
Top 10 Jungle, a provider of slick digital content and online product reviews for the medical alert industry, explains to seniors and medical alert customers how a government shutdown can affect them. Top 10 Jungle recently released its 2018...

19 jan 2018
The food recall warning issued on January 12, 2018 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Imperial Caviar...

19 jan 2018
The National Safety Council extends its deepest sympathies to Tom Petty's family, friends, band members and millions of fans as they grapple not only with his loss, but also with the knowledge that the musical icon was taken far too soon because of a...




News published on 5 october 2017 at 17:39 and distributed by: